The low cycle fatigue (LCF) behavior of as-cast Sn-0.7mass%Cu lead-free solder and compared with those of conventional Sn-37mass%Pb solder were investigated at strain rate 0.1%/s under various temperatures, R.T. (room temperature), 80 o C, 120 o C. In addition, the relationship between the surface feature in the LCF test and the fatigue life of these solders at R.T. were investigated. The fatigue life of Sn-0.7Cu decreased with increasing temperature. And the fatigue life of Sn-0.7mass%Cu was better than that of the Sn-37mass%Pb solder at R.T. and 80 o C. The surface deformation as fine meshes during the LCF test of Sn-0.7mass%Cu did not appear until 10% of fatigue life. Although over 10% of fatigue life, surface deformation that was caused by micro cracks and these link up occurred with increasing number of cycles.
The low-cycle fatigue behavior and the relationship between the surface features in the low-cycle fatigue testing and the fatigue life of Sn-3.5Ag and Sn-0.7Cu lead-free solders were investigated at strain rate of 0.1%/s with a non-contact extensometer at room temperature ( 22 o C), 80 o C and 120 o C. In addition the fatigue life using the surface deformation of those solders were defined and estimated from the surface features of solders investigated by image processing and compared with Coffin-Manson type of fatigue behavior of solders. The fatigue life of Sn-3.5Ag solder was superior to that of Sn-0.7Cu solder under temperatures of 80 o C and 120 o C. The fatigue life defined from surface deformation indicated a close behavior to Coffin-Manson type of fatigue behavior in those solders. This method could identify the low-cycle fatigue life of solders from the surface deformation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.